An Observational Study Measuring in a Non-invasive Approach the Nociception Level Index and Its Association With Pain and Anxieiy Perception Evaluated by Questionnaires, in Awake Women During Elective Cesarean Delivery Under Spinal Anesthesiaanxiety
A Prospective Observational Study Evaluating the Nociception Level Index and Its Association With Pain Perception, Anxiety, Uterine Activity, and Autonomic Responses During Elective Cesarean Delivery Under Spinal Anesthesia
The Nociception Level (NOL) Index is a multiparametric, non-invasive monitor that objectively assesses nociception by integrating several autonomic physiological signals. Although the NOL Index has been extensively validated during general anesthesia, its performance in awake patients undergoing regional anesthesia remains poorly understood. During cesarean delivery (CD) under spinal anesthesia, autonomic responses may be influenced not only by nociceptive stimulation but also by anxiety, uterine contractions, hemodynamic changes, uterotonic medications, and other non-nociceptive factors. Understanding the relative contribution of these factors is essential before the NOL Index can be reliably applied in awake surgical patients.
This prospective observational study aims to characterize the behavior of the NOL Index throughout elective CD performed under spinal anesthesia and to evaluate its relationship with subjective pain intensity, anxiety, uterine activity, perioperative autonomic responses, and routine physiological variables.
Approximately 100 women undergoing elective CD under spinal anesthesia will be enrolled at Carmel Medical Center. Continuous NOL monitoring using the PMD-200 system will be performed from before spinal anesthesia until the early postoperative period. Subjective pain (Visual Analog Scale), anxiety (Visual Analog Scale for Anxiety), uterine activity, hemodynamic variables, perioperative medications, and predefined surgical events will be prospectively recorded and synchronized with continuous NOL measurements. Potential confounding factors, including vasopressor administration, uterotonic drugs, nausea, shivering, patient movement, and supplemental analgesia, will also be documented.
This study will provide one of the first comprehensive evaluations of continuous NOL monitoring during CD under spinal anesthesia. The results are expected to improve the understanding of objective nociception monitoring in awake patients, clarify the influence of non-nociceptive autonomic activation on the NOL Index, and help define the clinical role and limitations of NOL monitoring during regional anesthesia, and may contribute to the future development of objective pain assessment strategies in obstetric anesthesia and other clinical settings involving awake patients.
研究概览
地位
条件
详细说明
Elective cesarean delivery performed under spinal anesthesia provides a unique and highly reproducible clinical model for investigating objective nociception monitoring in awake patients. Unlike patients undergoing general anesthesia, women receiving spinal anesthesia remain conscious throughout surgery, allowing simultaneous assessment of subjective pain perception, anxiety, autonomic physiological responses, and objective nociception monitoring under standardized surgical conditions.
The Nociception Level (NOL) Index is a multiparametric physiological monitoring system that integrates several autonomic variables, including heart rate variability, skin conductance, photoplethysmographic waveform characteristics, and additional physiological parameters using a proprietary machine-learning algorithm. The NOL Index has been extensively validated during general anesthesia and has demonstrated good correlation with surgical stimulation and analgesic adequacy. However, its performance during regional anesthesia, particularly in awake obstetric patients, remains insufficiently characterized.
During cesarean delivery under spinal anesthesia, multiple physiological and psychological factors may influence autonomic nervous system activity independently of nociceptive stimulation. These include preoperative and intraoperative anxiety, emotional stress, patient communication, uterine manipulation, uterine contractions following administration of uterotonic agents, hemodynamic changes associated with neuraxial anesthesia, vasopressor administration, nausea, shivering, and patient movement. Consequently, interpretation of the NOL Index in this setting requires further clinical investigation.
This prospective, single-center observational study will enroll approximately 100 women undergoing elective cesarean delivery under spinal anesthesia at Carmel Medical Center, Haifa, Israel. Standard perioperative management will not be modified for study purposes. Continuous NOL monitoring will begin before initiation of spinal anesthesia and continue throughout surgery and the early postoperative recovery period.
Simultaneously, subjective pain intensity will be assessed using the Visual Analog Scale (VAS), anxiety will be evaluated using the Visual Analog Scale for Anxiety (VAS-A), and routine physiological variables including heart rate, blood pressure, mean arterial pressure, and oxygen saturation will be recorded. Surgical milestones, administration of intrathecal medications, uterotonic agents, vasopressors, rescue analgesia, and other clinically relevant medications will be prospectively documented and synchronized with continuous NOL recordings.
The primary objective of the study is to characterize the intraoperative behavior of the NOL Index and determine the percentage of monitoring time during which NOL values remain outside the predefined target range of 10-25. Secondary objectives include evaluation of the relationships between the NOL Index and subjective pain intensity, anxiety, uterine activity, surgical phases, rescue analgesia requirements, and perioperative autonomic responses.
Potential confounding factors known to influence autonomic nervous system activity-including maternal anxiety, hypotension, vasopressor administration, uterotonic medications, nausea, shivering, supplemental analgesia, sedation, and patient movement-will be prospectively documented and considered during statistical analyses. Continuous NOL data will be automatically recorded according to the device sampling frequency and exported for offline analysis following predefined quality-control procedures.
The findings of this study are expected to improve understanding of objective nociception monitoring in awake patients undergoing regional anesthesia and to define the clinical utility and limitations of the NOL Index in obstetric anesthesia. The results may contribute to optimizing intraoperative pain assessment, improving interpretation of physiological monitoring during regional anesthesia, and guiding future research on objective nociception monitoring in conscious surgical patients.
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Michael Grach, MD Dr.
- 电话号码:+972506265753
- 邮箱:Grachm@gmail.com
研究联系人备份
- 姓名:Dana Kosh, MD Dr.
- 电话号码:972- 4-8250785
- 邮箱:Danako@clalit.org.il
学习地点
-
-
-
Haifa、以色列、3436212
- Carmel Medical Center
-
接触:
- Michael Grach, MD Dr.
- 电话号码:972-506265753
- 邮箱:Grachm@gmail.com
-
接触:
- Dana Kosh, MD Dr.
- 电话号码:972-4-8250785
- 邮箱:danako@clalit.org.il
-
-
参与标准
资格标准
适合学习的年龄
- 成人
接受健康志愿者
取样方法
研究人群
描述
Inclusion Criteria:
- Women ≥18 years
- Scheduled to elective cesarean delivery under spinal anesthesia
- ASA I-III
- Able to provide informed consent
Exclusion Criteria:
- Women Age <18 years
- BMI >35 kg/m²
- Major psychiatric illness
- Chronic psychotropic/anxiolytic therapy
- Substance abuse
- Inability to communicate
- Contraindication to spinal anesthesia
- Any pre condition interfering with study participation
学习计划
研究是如何设计的?
设计细节
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Percentage of intraoperative monitoring time during which the Nociception Level Index remains outside the predefined target range (10-25) during elective cesarean delivery under spinal anesthesia
大体时间:Intraoperative period up to 3 hours
|
Nociception Level Index a physiological parameter measurment obtained, in a non invasive way, by a probe attached to the index finger, recording every 5 seconds.
(range 0-100) 0 no pain 100 worst pain
|
Intraoperative period up to 3 hours
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Duration of Nociception Level Index (>25)
大体时间:Intraoperative period and approximately 1 hour postoperatively, up to 5 hours
|
Nociception Level Index a physiological parameter measurment obtained, in a non invasive way, by a probe attached to the index finger, recording every 5 seconds.
(range 0-100) 0 no pain 100 worst pain.
Recording duration when values exceeding over 25
|
Intraoperative period and approximately 1 hour postoperatively, up to 5 hours
|
|
Correlation between Nociception Level Index and Visual Analog Scale
大体时间:: Intraoperative period and approximately 1 hour postoperatively up to 5 hours
|
Correlation between Nociception Level Index a physiological parameter measurment obtained, in a non invasive way, by a probe attached to the index finger, recording every 5 seconds.
(range 0-100) 0 no pain 100 worst pain and Visual analog scale scores by questionnaires, range 1-10 at 3 time points: preoperative, 0- no pain 10 worst pain
|
: Intraoperative period and approximately 1 hour postoperatively up to 5 hours
|
|
Correlation between Nociception Level Index and Visual Analogue Scale- anxiety
大体时间:Intraoperative period and approximately 1 hour postoperatively up to 5 hours
|
Correlation between Nociception Level Index a physiological parameter measurment obtained, in a non invasive way, by a probe attached to the index finger, recording every 5 seconds.
(range 0-100) 0 no pain 100 worst pain and Visual analog scale- Anxiety scores by questionnaires, range 1-10 at 3 time points: preoperative, 0- no pain 10 worst pain
|
Intraoperative period and approximately 1 hour postoperatively up to 5 hours
|
|
Surgical phase analysis
大体时间:Intraoperative period and approximately 1 hour postoperatively
|
Intraoperative period and approximately 1 hour postoperatively
|
|
|
Association of Nociception Level Index with uterine activity
大体时间:Intraoperative period and approximately 1 hour postoperatively up to 5 hours
|
Nociception Level Index a physiological parameter measurment obtained, in a non invasive way, by a probe attached to the index finger, recording every 5 seconds.
(range 0-100) 0 no pain 100 worst pain.
Uterine activity as assessed by the surgeon to determine unterine contrations
|
Intraoperative period and approximately 1 hour postoperatively up to 5 hours
|
|
Rescue analgesia requirements
大体时间:Intraoperative period and approximately 1 hour postoperatively up to 5 hours
|
Recording analgesia requirements dosages
|
Intraoperative period and approximately 1 hour postoperatively up to 5 hours
|
合作者和调查者
出版物和有用的链接
一般刊物
- Ben-Israel N, Kliger M, Zuckerman G, Katz Y, Edry R. Monitoring the nociception level: a multi-parameter approach. J Clin Monit Comput. 2013 Dec;27(6):659-68. doi: 10.1007/s10877-013-9487-9. Epub 2013 Jul 9.
- Martini CH, Boon M, Broens SJ, Hekkelman EF, Oudhoff LA, Buddeke AW, Dahan A. Ability of the nociception level, a multiparameter composite of autonomic signals, to detect noxious stimuli during propofol-remifentanil anesthesia. Anesthesiology. 2015 Sep;123(3):524-34. doi: 10.1097/ALN.0000000000000757.
- Edry R, Recea V, Dikust Y, Sessler DI. Preliminary Intraoperative Validation of the Nociception Level Index: A Noninvasive Nociception Monitor. Anesthesiology. 2016 Jul;125(1):193-203. doi: 10.1097/ALN.0000000000001130.
- Meijer FS, Martini CH, Broens S, Boon M, Niesters M, Aarts L, Olofsen E, van Velzen M, Dahan A. Nociception-guided versus Standard Care during Remifentanil-Propofol Anesthesia: A Randomized Controlled Trial. Anesthesiology. 2019 May;130(5):745-755. doi: 10.1097/ALN.0000000000002634.
- Okur, N., Yıldırım, D., & Aydın, E. (2020). Evaluation of preoperative anxiety in pregnant women before elective cesarean section: Comparison of VAS and STAI scales. Journal of Obstetrics and Gynaecology Research, 46(1), 5-10. https://doi.org/10.1111/jog.14126
- Abend, R., Dan, O., Maoz, K., Raz, S., & Bar-Haim, Y. (2014). Reliability, validity and sensitivity of a computerized visual analog scale for anxiety. Cognition and Emotion, 28(8), 1434-1441. https://doi.org/10.1080/02699931.2014.881326
- Andersen T, Sandnes A, Hilland M, Halvorsen T, Fondenes O, Heimdal JH, Tysnes OB, Roksund OD. Laryngeal response patterns to mechanical insufflation-exsufflation in healthy subjects. Am J Phys Med Rehabil. 2013 Oct;92(10):920-9. doi: 10.1097/PHM.0b013e3182a4708f.
- Witteveen, A. B. et al. (2019). "Postpartum PTSD and its risk factors following emergency cesarean delivery." Arch Womens Ment Health, 22, 229-237. https://doi.org/10.1007/s00737-018-0918-5
- Fentie Y, Yetneberk T, Gelaw M. Preoperative anxiety and its associated factors among women undergoing elective caesarean delivery: a cross-sectional study. BMC Pregnancy Childbirth. 2022 Aug 17;22(1):648. doi: 10.1186/s12884-022-04979-3.
- 8. Sessler, D. I., & Devereaux, P. J. (2021).*Perioperative anesthetic management and long-term outcomes*. Anesthesiology, 134(5), 698-713. https://doi.org/10.1097/ALN.0000000000003707
- 7. Edry, R., Recea, V., Dikust, Y., Sessler, D. I., & Ezri, T. (2016). *Preliminary intraoperative evaluation of a novel nociception monitor in patients undergoing abdominal surgery*. British Journal of Anaesthesia, 117(4), 477-483. https://doi.org/10.1093/bja/aew223
- Meijer, F., Honing, M., Bom, A., Kalmar, A., Martini, C., & Struys, M. (2020). *Nociception-guided versus standard opioid administration during general anaesthesia: A meta-analysis of randomized controlled trials*. British Journal of Anaesthesia, 124(4), 474-483. https://doi.org/10.1016/j.bja.2019.12.034
- Van Driessche, F., Cromheecke, S., De Hert, S., & Rex, S. (2020). NOL-guided opioid administration during general anesthesia for cesarean section: A feasibility study. BMC Anesthesiology, 20, Article 80. https://doi.org/10.1186/s12871-020-01026-0
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 0005-26-CMC
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.